Valion Bio (VBIO) Operating Expenses (2021 - 2026)
Valion Bio (VBIO) recorded Operating Expenses of $6.42 million in Q2 2026, up 282.8% from $1.68 million a year earlier.
Powered by 
Analysis
Valion Bio (VBIO) Operating Expenses (2021 - 2026) Analysis & Trends
On a TTM basis, Valion Bio's Operating Expenses came in at $12.46 million as of Jun 30, 2026, up 161.4% year-over-year; for FY2025, it was $7.9 million, up 76.5% from FY2024.
- Annual Operating Expenses has a four-year compound annual growth rate of 9.0% (FY2021 to FY2025).
- Across earlier years, Operating Expenses came in at $4.48 million in FY2024 (-47.5%), $8.53 million in FY2023 (-17.9%), $10.4 million in FY2022 (+85.8%) and $5.6 million in FY2021.
- The Q2 2026 figure is the highest quarterly Operating Expenses in data going back to Q1 2021.
- On a year-over-year basis, Operating Expenses rose in three of the last six quarters, with growth averaging 41.1%.
- Peak year-over-year performance for Operating Expenses in the last five years was growth of 282.8% in Q2 2026, against a decline of 97.5% in Q4 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 7.95 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 11.12 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 10.56 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | 12.80 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 6.09 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 9.70 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 6.54 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | 18.20 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 6.68 Bn |
| 10 | Valion Bio | 125,763.04 | -19.31 Mn | - | 6.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.42 Mn |
| Dec 31, 2025 | 2.02 Mn |
| Sep 30, 2025 | 2.34 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 1.56 Mn |
| Dec 31, 2024 | 57,000.00 |
| Sep 30, 2024 | 1.48 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | 2.25 Mn |
| Sep 30, 2023 | 1.87 Mn |
| Jun 30, 2023 | 2.19 Mn |
| Mar 31, 2023 | 2.23 Mn |
| Dec 31, 2022 | 2.30 Mn |
| Sep 30, 2022 | 2.65 Mn |
| Jun 30, 2022 | 3.14 Mn |
| Mar 31, 2022 | 2.31 Mn |
| Dec 31, 2021 | 2.29 Mn |
| Sep 30, 2021 | 1.20 Mn |
| Jun 30, 2021 | 1.02 Mn |
API Access
Valion Bio Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();